Search
Returning search results with filters:
Remove filter for
Category: Drugs
Remove filter for
Recall class: Type II
Clear all
Search filters
Type
Audience
Category
Issue
Last updated
Recall class
Displaying 1 - 15 of 209 items.
Teva-Topilene 0.05% Ointment: Out of Specification
RecallHealth product recall | 2024-06-27
JAMP-Doxazosin 4 mg: The uniformity of dosage unit may be out of specification in the affected lot.
RecallHealth product recall | 2024-06-25
Taisho Pharmaceutical Pabron Gold A (Granules) unlicensed product:, product is labelled to contain dihydrocodeine phosphate that is listed on Schedule I of the CDSA
RecallHealth product recall | 2024-06-10
Sanis Health Duloxetine 60 mg Capsule; Exceeds acceptable interim intake limit for N-nitroso-duloxetine (NDLX)
RecallHealth product recall | 2024-05-16
Sandoz Fesoterodine Fumarate 8 mg tablet; Out-of-specification (diester impurity)
RecallHealth product recall | 2024-05-16
JAMP-Guanfacine XR 4 mg: Foreign matter
RecallHealth product recall | 2024-04-10
JAMP-Rabeprazole 20 mg: Affected lot may contain JAMP-Rabeprazole 10 mg
RecallHealth product recall | 2024-04-02
FOLIC ACID 1MG - Affected lots exceed or may exceed the acceptable intake limit for N-nitroso-folic acid.
RecallHealth product recall | 2024-03-12
TEVA-DILTIAZEM XC: Out of specification
RecallHealth product recall | 2024-02-07
JAMP TELMISARTAN-HCT: Affected lots may contain higher dosage than the labelled dose
RecallHealth product recall | 2024-01-24
PEDIATRIX ORAL SOLUTION 100mg: Out of specification
RecallHealth product recall | 2024-01-15
Life Brand Long Lasting Decongestant Nasal Spray 15 mL: Labelled with incorrect Drug Facts Table
RecallHealth product recall | 2024-01-04
Life Brand Decongestant Nasal Spray 20 mL: Labelled with incorrect Drug Facts Table
RecallHealth product recall | 2024-01-04
Privigen: Series of adverse reactions
RecallHealth product recall | 2023-12-21
Claritin® Kids Rapid Dissolve 5 mg: Potential contamination
RecallHealth product recall | 2023-12-20